News
VitaFlow Liberty™ Completes Implantations across 15 Hospitals on the First Day after Market Launch - 27 Sep 2021
MicroPort CardioFlow Medtech Corporation (CardioFlow Medtech) announce...MicroPort® Completes Subject Enrollment for Firesorb® FUTURE-III Pivotal Trial - 27 Sep 2021
Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort®), has complet...MicroPort® Announces Strategic Investment with Kerui Pharma - 13 Sep 2021
MicroPort Scientific Corporation (MicroPort®) announced that its subsi...MicroPort® NeuroTech NUMEN Coil Embolization System Approved for Market in Korea - 10 Sep 2021
The NUMEN® Coil Embolization System (NUMEN®) and NUMEN FR® Detachment ...Products Complete First Implantations in the UK Following Endovastec’s Entry into the UK Market - 08 Sep 2021
Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (Endovastec™...MicroPort® Toumai® Laparoscopic Surgery Robot Becomes First in China to Complete Experimental Sleeve Lobectomy in Animals - 07 Sep 2021
The Toumai® Laparoscopic Surgery Robotic System (Toumai®), developed b...MicroPort® EP Products Debut in First Procedure in Kazakhstan - 07 Sep 2021
Shanghai MicroPort® EP MedTech Co., Ltd. (MicroPort EP) recently annou...MicroPort® NeuroTech Completes First Implantation of NUMEN® Coil Embolization System in Chile, Marking Their Debut in an Overseas Market - 03 Sep 2021
The NUMEN® Coil Embolization System (NUMEN®) has been implanted in a p...First Motorized Retrievable Transcatheter Aortic Valve (TAVI) System - VitaFlow Liberty™ received approval for marketing in China - 01 Sep 2021
On 31st August 2021, MicroPort CardioFlow Medtech Corporation (CardioF...MicroPort® Announces 2021 Interim Results - 31 Aug 2021
MicroPort Scientific Corporation (hereafter referred to as the "Compan...CardioFlow Medtech Announces 2021 Interim Results - 31 Aug 2021
MicroPort CardioFlow Medtech Corporation announced on August 29, 2021 ...MicroPort® EP and Stereotaxis Collaborate to Advance Innovation and Adoption of Robotic Electrophysiology in China - 30 Aug 2021
Shanghai MicroPort® EP MedTech Co., Ltd (MicroPort® EP) and Stereotaxi...MicroPort® EP OptimAblate™ Tubing Set Receives NMPA Marketing Approval - 30 Aug 2021
Shanghai MicroPort EP MedTech Co., Ltd., (MicroPort® EP), has recently...MSC Completes First Patient Enrollment for Multicenter Post-Marketing Clinical Study ‘China Pace’ - 25 Aug 2021
The first patient enrollment for the ‘China Pace’ post-marketing clini...Firehawk®, Foxtrot® NC and Foxtrot® Pro PTCA Balloon Catheters Receive Approval in Turkmenistan - 15 Aug 2021
Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort®) has recently...CardioFlow Medtech’s Next-generation Alwide® Plus Balloon Catheter Approved for Marketing in China - 13 Aug 2021
Alwide® Plus, the next-generation valve balloon dilation catheter deve...